Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new clopidogrel clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on clopidogrel
- Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
Status: Not yet recruiting, Condition Summary: Coronary Artery Disease - A Clinical Trial to Demonstrate the Efficacy of Cangrelor.
Status: Recruiting, Condition Summary: Unstable Angina; Myocardial Infarction; Acute Coronary Syndromes - Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Status: Recruiting, Condition Summary: Acute Coronary Syndrome; Myocardial Infarction; Coronary Artery Disease; Percutaneous Coronary Intervention - Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
Status: Not yet recruiting, Condition Summary: Coronary Artery Disease - Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Status: Completed, Condition Summary: Arteriosclerosis - Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance
Status: Recruiting, Condition Summary: Acute ST SEgment Elevation Myocardial Infarction - Healthy Volunteer Study of Clopidogrel and Rifampicin
Status: Completed, Condition Summary: Coronary Artery Disease - Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Status: Recruiting, Condition Summary: Coronary Artery Disease - Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function
Status: Completed, Condition Summary: Coronary Artery Disease - A Comparison of AZD6140 and Clopidogrel in Patients With Acute Coronary Syndrome
Status: Recruiting, Condition Summary: Acute Coronary Syndrome - Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
Status: Recruiting, Condition Summary: Coronary Artery Disease - H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel
Status: Completed, Condition Summary: Coronary Artery Disease; Elective Percutaneous Coronary Intervention - Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation
Status: Recruiting, Condition Summary: Heart Defects, Congenital - The Effects of Physical Training, ASA and Clopidogrel on the Walking Capacity of Patients With Stage II PAD
Status: Active, not recruiting, Condition Summary: Peripheral Vascular Disease - Pharmacodynamics of CGT 2168 Compared With Plavix®
Status: Active, not recruiting, Condition Summary: Healthy - A Study of the Antiplatelet Effects Comparing AZD6140 With Clopidogrel Responder and Non-Responders
Status: Recruiting, Condition Summary: Stable Coronary Artery Disease - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)
Status: Recruiting, Condition Summary: Diabetes Mellitus; Coronary Artery Disease - A Study of the Onset and Offset of Antiplatelet Effects Comparing AZD6140, Clopidogrel, and Placebo With Aspirin
Status: Recruiting, Condition Summary: Coronary Artery Disease - Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation
Status: Recruiting, Condition Summary: Coronary Artery Disease - Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
Status: Terminated, Condition Summary: Atrial Fibrillation; Vascular Risk - Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
Status: Recruiting, Condition Summary: Coronary Arteriosclerosis; Acute Coronary Syndrome - PACT (Platelet Activity After Clopidogrel Termination)
Status: Recruiting, Condition Summary: Blood Platelets; Clopidogrel - Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function
Status: Completed, Condition Summary: Peripheral Arterial Disease - Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg
Status: Completed, Condition Summary: Healthy - Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg
Status: Completed, Condition Summary: Healthy - CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
Status: Recruiting, Condition Summary: Myocardial Infarction - The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
Status: Recruiting, Condition Summary: Heart Catheterization - Doubling the Maintenance Dose of Clopidogrel After Percutaneous Coronary Intervention in Low Responders to Therapy
Status: Recruiting, Condition Summary: Stable Angina Pectoris; Percutaneous Coronary Intervention - Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Status: Not yet recruiting, Condition Summary: Coronary Artery Disease; Myocardial Ischemia; Bleeding - The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol
Status: Recruiting, Condition Summary: Clopidogrel Non-Responsiveness